Garvan researchers will lead a project to map 2,000 cancer samples, aiming to understand why treatments vary across patients and cancer types. This initiative involves one of the largest collaborative cancer studies between Australia and Japan.

ow.ly/XPIF50UZTQe

New Garvan research reveals how hepatitis C triggers autoimmunity through B cell mutations – not molecular mimicry as previously thought.

Published in @ImmunityCP, this could transform treatment approaches for a range of autoimmune diseases.

ow.ly/UlzN50UHio7

A new multinational collaboration co-led by the Garvan has found new discoveries which could improve cancer treatment.

Read more about this important research here: ow.ly/fvmr50UgqVo

Have you heard of our podcast Medical Minds?

Don't miss out on our episode about inflammatory bowel disease, where we spoke to Dr Kylie James!

Click here to listen: ow.ly/p7cW50UfpLH